Your browser doesn't support javascript.
loading
NCCN Guidelines Insights: Breast Cancer, Version 3.2018.
Goetz, Matthew P; Gradishar, William J; Anderson, Benjamin O; Abraham, Jame; Aft, Rebecca; Allison, Kimberly H; Blair, Sarah L; Burstein, Harold J; Dang, Chau; Elias, Anthony D; Farrar, William B; Giordano, Sharon H; Goldstein, Lori J; Isakoff, Steven J; Lyons, Janice; Marcom, P Kelly; Mayer, Ingrid A; Moran, Meena S; Mortimer, Joanne; O'Regan, Ruth M; Patel, Sameer A; Pierce, Lori J; Reed, Elizabeth C; Rugo, Hope S; Sitapati, Amy; Smith, Karen Lisa; Smith, Mary Lou; Soliman, Hatem; Telli, Melinda L; Ward, John H; Young, Jessica S; Shead, Dorothy A; Kumar, Rashmi.
Afiliação
  • Goetz MP; 1Mayo Clinic Cancer Center.
  • Gradishar WJ; 2Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Anderson BO; 3University of Washington/Seattle Cancer Care Alliance.
  • Abraham J; 4Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Aft R; 5Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Allison KH; 6Stanford Cancer Institute.
  • Blair SL; 7UC San Diego Moores Cancer Center.
  • Burstein HJ; 8Dana-Farber/Brigham and Women's Cancer Center.
  • Dang C; 9Memorial Sloan Kettering Cancer Center.
  • Elias AD; 10University of Colorado Cancer Center.
  • Farrar WB; 11The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Giordano SH; 12The University of Texas MD Anderson Cancer Center.
  • Goldstein LJ; 13Fox Chase Cancer Center.
  • Isakoff SJ; 14Massachusetts General Hospital Cancer Center.
  • Lyons J; 4Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Marcom PK; 15Duke Cancer Institute.
  • Mayer IA; 16Vanderbilt-Ingram Cancer Center.
  • Moran MS; 17Yale Cancer Center/Smilow Cancer Hospital.
  • Mortimer J; 18City of Hope National Medical Center.
  • O'Regan RM; 19University of Wisconsin Carbone Cancer Center.
  • Patel SA; 13Fox Chase Cancer Center.
  • Pierce LJ; 20University of Michigan Rogel Cancer Center.
  • Reed EC; 21Fred & Pamela Buffett Cancer Center.
  • Rugo HS; 22UCSF Helen Diller Family Comprehensive Cancer Center.
  • Sitapati A; 7UC San Diego Moores Cancer Center.
  • Smith KL; 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Smith ML; 24Research Advocacy Network.
  • Soliman H; 25Moffitt Cancer Center.
  • Telli ML; 6Stanford Cancer Institute.
  • Ward JH; 26Huntsman Cancer Institute at the University of Utah.
  • Young JS; 27Roswell Park Comprehensive Cancer Center; and.
  • Shead DA; 28National Comprehensive Cancer Network.
  • Kumar R; 28National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 17(2): 118-126, 2019 02.
Article em En | MEDLINE | ID: mdl-30787125
ABSTRACT
These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article